… cancer-related mortality in patients with type 2 diabetes. We hypothesized that people with
type 2 diabetes exposed to sulfonylureas … have an increased risk of cancer-related mortality …

… sulfonylureas during the observation period in our retrospective analysis. We did explore the
cancerrelated mortality in … number of events (ie, cancerrelated mortalities) in the metformin …

… of cancer-related deaths worldwide occur in China (3). Epidemiologic studies have suggested
that diabetes can increase … that sulfonylurea was potentially associated with the increased …

… 5B) suggests that studies reporting an increased risk of cancer among sulfonylurea users …
the presence of publication bias for studies investigating the use of sulfonylurea and cancer. …

… -lowering drug (GLD) use, including metformin, sulphonylurea derivatives and insulin, after
… sulphonylurea derivative use was associated with increased breast cancer-specific mortality…

… In addition, several observational studies have associated their use with an increased risk
of cancer incidence and cancer-related mortality compared with other oral antidiabetic agents (…

… between cancer mortality and insulin or sulfonylureas use was … overweight diabetic cohort
and could justify why patients on … , showed a higher cancer-related mortality than patients on …

… Among type 2 diabetic patients receiving combinations of metformin and sulphonylureas,
we have recently observed a significantly higher all-cause mortality in those treated with …

… type 2 diabetes: metformin monotherapy, sulfonylurea monotherapy, combination therapy with
metformin plus sulfonylureas… increased smoking incidence in insulin-treated patients; 70% …

… increased risk of cancer mortality associated with sulfonylurea monotherapy use compared
with metformin use (alone … with sulfonylurea), as well as an increased risk of cancer mortality …